| Study name |
PROTRACT |
| Methods |
RCT |
| Participants |
Men with testicular cancer undergoing 3 cycles of combination chemotherapy with bleomycin, etoposide, and cisplatin (BEP) |
| Interventions |
HIPRT compared to standard care |
| Outcomes |
Primary outcomes include mean fiber area and fiber type composition measured by histochemical analyses, satellite cells and levels of protein and mRNA expression of intracellular mediators of protein turnover. Secondary outcomes include maximum muscle strength and muscle power measured by maximum voluntary contraction and leg‐extensor‐power tests, body composition assessed by DXA scan, and systemic inflammation analyzed by circulating inflammatory markers, lipid and glucose metabolism in blood samples. HRQoL outcomes assessed using the QLQ‐C30 and SF‐36 |
| Starting date |
Not reported |
| Contact information |
Jesper F Christensen, University Hospital Centre for Nursing and Care Research, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark |
| Notes |
Published protocol. Trial Registration: Current Controlled Trials ISRCTN32132990 |
